Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02182622
Title LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel
Recruitment Withdrawn
Gender male
Phase Phase I
Variant Requirements No
Sponsors Martin Gutierrez
Indications

prostate adenocarcinoma

Therapies

Docetaxel

Sonidegib

Age Groups: adult
Covered Countries USA


No variant requirements are available.